Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
547
NCT05664334
Safety and Immunogenicity of IVX-A12 in Healthy Older Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 21, 2022
Completion: Jan 24, 2024
NCT05903183
A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age
Phase: Phase 2
Start: May 15, 2023
Completion: Sep 30, 2025
NCT06481579
A Study of IVX-A12 in Adults Participants
Start: Jun 10, 2024
Completion: Dec 19, 2024